Taylor & Francis Group
Browse
ihuf_a_2266619_sm0973.doc (46.5 kB)

Chinese herbal medicines as complementary therapy to in vitro fertilization-embryo transfer in women with infertility: protocols and applications

Download (46.5 kB)
journal contribution
posted on 2023-11-08, 13:00 authored by Hui Chang, Tsz Ching Yeung, Xinming Yang, Jingshu Gao, Xiaoke Wu, Chi Chiu Wang

In vitro fertilization-embryo transfer (IVF-ET) is a very common treatment for couples with infertility. However, IVF-ET still has a limited success rate with high costs. Chinese herbal medicines (CHM) have been used as complementary treatments for infertility to improve the reproductive outcomes during different stages of the IVF-ET cycle. This review provides an up to date evidence on CHM treatments. We summarize the treatment protocols based on the stages of IVF-ET cycle and discuss its clinical applications in IVF-ET treatment. The possible underlying mechanisms of CHM include improving ovarian function, promoting endometrial receptivity, regulating immune function, inhibiting oxidation, and reducing mental stress and discomfort during treatment. This review aims to provide information and guidance on the potential clinical applications of CHM as an adjuvant therapy during IVF-ET treatment.

Funding

This work was financially supported by the National Natural Science Foundation of China (Youth Project) (Grant number 82004404); the grant of China Postdoctoral Science Foundation (Grant numbers 2021T140188 and 2018M641886); the National Key Research and Development Program of China (2019YFC1709500); the Project of Heilongjiang Province “TouYan” Innovation Team; the fourth batch of Heilongjiang Province traditional Chinese medicine expert Han Yanhua academic experience successor project; the second batch of TCM clinical outstanding talents training program in Heilongjiang Province.

History